Category: Investigator news

Chatelaine shares AllerGen, CHILD food allergy research results

A new article in Chatelaine magazine highlights the latest developments in the fight against food allergies, providing national exposure for AllerGen investigators, trainees, partner organizations and AllerGen-supported food allergy research. “How Close Are We to a Cure for Food Allergies?”

Interview videos highlight CHILD research

A January 2018 video interview with AllerGen investigator Dr. Meghan Azad, entitled “Meghan Azad on Studying Chronic Diseases in Children” and produced by the Human Capital and Economic Opportunity (HCEO) Global Working Group, explores Dr. Azad’s work on the developmental

AllerGen researchers recognized for excellence by CSACI

Four AllerGen investigators were recently recognized with awards by the Canadian Society of Allergy and Clinical Immunology (CSACI) at that organization’s 2017 Annual Scientific Meeting. Dr. Susan Waserman was named the inaugural recipient of the Milton Gold Memorial Lectureship, “presented

Dr. Brett Finlay inducted into Canadian Medical Hall of Fame

AllerGen investigator Dr. Brett Finlay (The University of British Columbia) is one of six 2018 inductees to the Canadian Medical Hall of Fame. Laureates of this honour are individuals whose contributions to medicine and the health sciences have led to

AllerGen researcher featured in CIHR breastfeeding panel

On August 2, 2017, AllerGen investigator Dr. Meghan Azad (University of Manitoba) participated in a panel discussion organized by the CIHR’s Institute of Human Development, Child & Youth Health (IHDCYH) on breastfeeding and children’s health. In the event, Dr. Azad

Canadian allergists/immunologists comment on recent Australian oral immunotherapy study

AllerGen investigators Drs Manel Jordana and Susan Waserman and AllerGen HQP Dr. Derek Chu have prepared a statement in response to a recent Australian study being heralded as a “breakthrough” and a “cure” for peanut allergy. The paper, published in

Phase III trial shows new drug can help patients with severe asthma reduce oral steroids

An international study has shown that a new injectable drug (benralizumab) successfully targets the receptor of the immune system protein interleukin-5 (IL-5), allowing patients with hard-to-control asthma associated with blood or sputum eosinophils to reduce or discontinue oral steroids while

Virtual breastfeeding communities: a project inspired at AllerGen event

What do Instagram, breastfeeding, a Manitoba-based epidemiologist and an Alberta-based digital technology expert have in common? They all come together in a new research project, with the AllerGen network as the catalyst. At AllerGen’s 2016 Research Conference in Vancouver, BC,

Pet exposure during early life affects infant gut microbiota

Owning a cat or dog might be a good thing when it comes to reducing the risk of childhood allergies and obesity, according to new findings from the Canadian Healthy Infant Longitudinal Development (CHILD) Study. The research, published in the

AllerGen authors on 2016 Science Book Awards shortlist

Let Them Eat Dirt, a book based on research into how the microbes in our body contribute to our lifelong health, is on the shortlist for the 2016 Science in Society General Book Award. AllerGen investigator Dr. B. Brett Finlay

New microbiome book highlights AllerGen research

A new book, describing the “seed-and-feed” process by which a baby’s gut microbiome is established, features AllerGen investigator Dr. Anita Kozyrskyj and her research using CHILD Study data. Written for the general public, Your Baby’s Microbiome: The Critical Role of

CHILD Study in The Economist

The Economist magazine highlights the CHILD Study in its February 25, 2017, issue. The article, “Four good bugs,” profiles research led by AllerGen investigator Dr. Brett Finlay of The University of British Columbia, which looks at the relationship between gut

Top